Feb 16, 2016 21:01 pm UTC| Business
Primary endpoint at week 12 against placebo achieved p value of 0.0001; statistically significant and clinically meaningful pain relief demonstrated at weeks 1 through 16Zilretta also achieved statistical significance on...
Cerner Reports Fourth Quarter and Full Year 2015 Results
Feb 16, 2016 21:01 pm UTC| Business
KANSAS CITY, Mo., Feb. 16, 2016 -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2015 fourth quarter and full year that ended January 2, 2016. Bookings in the fourth quarter of 2015 were $1.35...
Fossil Group, Inc. Reports Fourth Quarter and Fiscal Year 2015 Results
Feb 16, 2016 21:01 pm UTC| Business
Fourth Quarter Net Sales of $993 Million; Diluted EPS of $1.46 Fiscal Year 2015 Net Sales of $3.229 Billion; Diluted EPS of $4.51 Provides First Quarter and Fiscal 2016 Guidance RICHARDSON, Texas, Feb. 16, 2016 --...
AGTC CEO to Present at the RBC Capital Markets Global Healthcare Conference on February 23, 2016
Feb 16, 2016 21:01 pm UTC| Business
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 16, 2016 -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
Legacy Reserves LP Announces 2015 Schedules K-1 Available
Feb 16, 2016 21:01 pm UTC| Business
MIDLAND, Texas, Feb. 16, 2016 -- Legacy Reserves LP (“Legacy”) (NASDAQ:LGCY) announced today that it has completed the 2015 tax packages for unitholders of LGCY, LGCYP and LGCYO including Schedules K-1. The tax packages...
HTG Molecular Diagnostics Establishes Immuno-Oncology Scientific Advisory Board
Feb 16, 2016 21:01 pm UTC| Business
TUCSON, Ariz., Feb. 16, 2016 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced the establishment of a Scientific Advisory...
Cytokinetics, Inc. Reports Fourth Quarter 2015 Financial Results
Feb 16, 2016 21:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 16, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) reported total research and development revenuesfor the fourth quarter of 2015 were $9.8 million, compared to $21.8 million, which included...